Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Genes, Chromosomes & Cancer|February 24, 2015
Microarray analysis of differentially expressed genes in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomiesKristina Veskimäe, Synnöve Staff, Francesco Tabaro, et al.
The American Journal of Surgical Pathology|August 17, 2012
Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practicesSatu Maria Remes, Vilppu J Tuominen, Heikki Helin, et al.
Immunology Letters|December 31, 2005
Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1Barbara Zsebik, Ami Citri, Jorma Isola, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Ultra thin needle histology may have impact in diagnosing chronic pancreatitisJuhani Sand, Taneli Tani, Johanna Laukkarinen, et al.
Journal of Pathology Informatics|June 19, 2018
Optimized JPEG 2000 Compression for Efficient Storage of Histopathological Whole-Slide ImagesHenrik Helin, Teemu Tolonen, Onni Ylinen, et al.
BMC Cancer|May 4, 2018
Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activationMark Barok, Maija Puhka, Gyorgy Vereb, et al.
Journal of Neuro-Oncology|May 17, 2006
Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expressionKatariina Korhonen, Tiina Salminen, Jani Raitanen, et al.
Virchows Archiv : an International Journal of Pathology|October 24, 2015
Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistryHenrik O Helin, Vilppu J Tuominen, Onni Ylinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancerNina Linder, Johan Lundin, Jorma Isola, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Allelic imbalance of HER2 variant in sporadic breast and ovarian cancerMarjut Puputti, Harri Sihto, Jorma Isola, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Genes, Chromosomes & Cancer|February 24, 2015
Microarray analysis of differentially expressed genes in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomiesKristina Veskimäe, Synnöve Staff, Francesco Tabaro, et al.
The American Journal of Surgical Pathology|August 17, 2012
Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practicesSatu Maria Remes, Vilppu J Tuominen, Heikki Helin, et al.
Immunology Letters|December 31, 2005
Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1Barbara Zsebik, Ami Citri, Jorma Isola, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Ultra thin needle histology may have impact in diagnosing chronic pancreatitisJuhani Sand, Taneli Tani, Johanna Laukkarinen, et al.
Journal of Pathology Informatics|June 19, 2018
Optimized JPEG 2000 Compression for Efficient Storage of Histopathological Whole-Slide ImagesHenrik Helin, Teemu Tolonen, Onni Ylinen, et al.
BMC Cancer|May 4, 2018
Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activationMark Barok, Maija Puhka, Gyorgy Vereb, et al.
Journal of Neuro-Oncology|May 17, 2006
Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expressionKatariina Korhonen, Tiina Salminen, Jani Raitanen, et al.
Virchows Archiv : an International Journal of Pathology|October 24, 2015
Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistryHenrik O Helin, Vilppu J Tuominen, Onni Ylinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancerNina Linder, Johan Lundin, Jorma Isola, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Allelic imbalance of HER2 variant in sporadic breast and ovarian cancerMarjut Puputti, Harri Sihto, Jorma Isola, et al.
Pageof 15